发明名称 INHIBITION OF C. DIFFICILE INFECTIONS BY INDIGESTIBLE OLIGOSACCHARIDES.
摘要 <p>The primary etiology of antibiotic-associated diarrhea (also known as pseudomembranous colitis) has been recognized as Clostridium difficile. It is believed that the indigenous microflora of a healthy individual suppresses the normally present C. difficile. However, when the indigenous microflora are disrupted (e.g., during antibiotic treatment) overgrowth of C. difficile may occur causing diarrhea and colitis. Treatment of C. difficile with antibiotics has proven effective, but many times relapse occurs; and dehydration due to diarrhea is an exacerbating problem. It has been suggested that normalization of the microflora will inhibit C. difficile relapse. Indigestible oligosaccharides have been shown to inhibit C. difficile infection. An oral rehydration solution containing such indigestible oligosaccharides also provides fluid and electrolyte replacement.</p>
申请公布号 MX9707631(A) 申请公布日期 1998.04.30
申请号 MX19970007631 申请日期 1996.04.04
申请人 ABBOTT LABORATORIES 发明人 KEITH ALLEN GARLEB;BRIAN WARREN WOLF;KEITH BRIAN WHEELER;SHELIA MARTINSON CAMPBELL;JOSEPH EDWARD WALTON;JONATHAN ALLAN MEULBROEK
分类号 C07H3/04;A61K31/70;A61K31/7016;A61K31/702;A61K33/00;A61K33/14;A61P1/00;A61P7/00;C07H3/06;(IPC1-7):A61K31/70 主分类号 C07H3/04
代理机构 代理人
主权项
地址